CRISPR tool kills cells by recognizing RNA

Scientists have developed a CRISPR-based tool that detects a specific RNA strand and, when that strand is present, triggers cell death. The difference from existing CRISPR methods is fundamental: instead of cutting or editing DNA, this system responds to the presence of particular RNA inside the cell.

RNA (ribonucleic acid) is the molecular messenger that translates information from DNA into proteins. Cancer cells and virus-infected cells often produce abnormal RNA sequences absent in healthy cells. That makes RNA an attractive target: specific cells can be identified without touching the DNA itself.

Precision cell elimination

In the tests, the system was directed at cancer cells and virus-infected cells. It recognized the target RNA and then activated a pathway that triggered cell death (apoptosis). Healthy cells lacking the specific RNA were left unaffected.

The technology is still at an early stage. Experiments were conducted in cell cultures, not in living organisms. Moving to animal models and eventually humans requires years of additional research. Questions about off-target effects, delivery mechanisms in the body, and system stability remain unanswered.

Complement to existing approaches

Existing methods for killing specific cells, such as CAR-T cell therapy, rely on proteins at the cell surface. This works well when such a protein is sufficiently unique to the target cell. But not all cancer cells carry a usable surface protein. RNA-based recognition offers an alternative, because the internal gene activity of a cell can serve as a distinguishing feature.

The combination of precision and flexibility makes this type of system an interesting subject for further research into cell-targeted therapies for cancer and infectious diseases.